Table of Contents

The Psychiatric Interview: Adapting to Diverse Settings.- Cultural and Social Context of Clinical Assessment.- Listening to the Patient.- The Physician–Patient Relationship.- The Psychiatric Interview: General Structures and Techniques.- Professional Ethics and Boundaries.- Legal Issues in Psychiatric Practice.- Psychiatric Perspective in Human Development.- Infant Development: The First 3 Years of Life.- Preschool Development.- School-Age Development.- Adolescent Development.- Adult and Midlife Development.- Late Life Development.- Development of Personality Throughout the Life Cycle.- Neurobiological Foundations of Psychiatry: Overview.- Evolutionary Psychiatry.- Genetic Epidemiology and Molecular Genetics.- Multiomics Approaches in Psychiatric Disorders.- Gut Microbiome and Psychiatric Disorders.- Gene-Environment Interactions.- Cognitive Neuroscience.- Neurobiology of Schizophrenia.- Neurobiology of Mood Disorders.- Neurobiology of Anxiety Disorders.- Neurobiology of Addiction.-Neurobiology of Autism Spectrum Disorder.- Neurobiology of Attention Deficit Hyperactivity Disorder.- Neurobiology of Dementia and Other Neurodegenerative Disorders.- Neurobiology of Neuroimmune Encephalitic Disorders.- Neurobiological Foundations of Psychotherapies.- Psychiatric Epidemiology.- Sociocultural Anthropology Models of Mental Function and Behavior.- Social Psychology Models of Mental Function and Behavior.- Psychoanalytic/Psychodynamic Models of Mental Function and Behavior.- Cognitive and Behavioral Models of Mental Function and Behavior.- Positive Psychology Model of Mental Function and Behavior.- Multimodal Clinical Evaluation and Treatment Planning.- Consciousness, Memory, and Intelligence.- Alterations of Speech, Thought, Perception, and Self-Experience.- Emotions.- Behavior and Adaptive Functioning.- Physical Signs and Symptoms.- Neuropsychological and Neurophysiological Assessment.- Brain Imaging in Psychiatry.- Integrative Neurobiological Approaches to Assessment.-Assessment Tools in Psychiatry.- Special Considerations in the Psychiatric Evaluation Across the Lifespan (Special Emphasis on Children, Adolescents, and Elderly).- Culture-Related Issues in Assessment.- Special Issues in Assessment.- The Psychiatric Formulation.- Psychiatric Classification.- Neurodevelopmental Disorders: Intellectual Disability.- Neurodevelopmental Disorders: Speech and Language Disorders.- Neurodevelopmental Disorders: Autism Spectrum Disorder.- Neurodevelopmental Disorders: Attention-Deficit/ Hyperactivity Disorder.- Neurodevelopmental Disorders: Learning Disorders.- Neurodevelopmental Disorders: Stereotypical Movement Disorders and Tic Disorders.- Schizophrenia and Other Primary Psychotic Disorders.- Depressive Disorders.- Bipolar Disorders.- Premenstrual Dysphoric Disorder and Peripartum Depression.- Childhood Mood Disorders: Depressive Disorders, Bipolar Disorders, and Disruptive Mood Dysregulation Disorder.- Anxiety and Fear-Related Disorders: Generalized Anxiety Disorder.- Anxiety and Fear-Related Disorders: Social Anxiety and Specific Phobia.- Anxiety and Fear-Related Disorders: Panic Disorder and Agoraphobia.- Anxiety Anxiety Disorder in Youth: Separation Anxiety, Social Anxiety, and Generalized Anxiety Disorders.- Obsessive-Compulsive and Related Disorders.- Obsessive-Compulsive Disorder Related Disorders: Hypochondriasis, Hoarding Disorder, Olfactory Reference Disorder, Body Dysmorphic Disorder, Trichotillomania, Excoriation Disorder.- Disorders Specifically Associated with Stress: PTSD, Complex PTSD, Acute Stress Reaction, Adjustment Disorder.- Disorders Specifically Associated with Stress: Reactive attachment disorders and disinhibited social engagement disorder.- Dissociative Disorders.- Feeding and Eating Disorders.- Childhood Elimination Disorders.- Disorders of Bodily Distress and Bodily Experience.- Sleep and Sleep–Wake Disorders.- Sexual Dysfunctions.- Gender Incongruence.- Disorders Due to Substance Use: General Approaches.- Disorders Due to Substance Use: Alcohol Abuse and Addiction.- Disorders Due to Substance Use: Caffeine.- Disorders Due to Substance Use: Cannabis.- Disorders Due to Substance Use: Phencyclidine.- Disorders Due to Substance Use: Hallucinogens and MDMA-related Substances.- Disorders Due to Substance Use: Inhalants.- Disorders Due to Substance Use: Opioids and Opioid Addiction.- Disorders Due to Substance Use: Sedatives, Hypnotics, and Anxiolytics.- Disorders Due to Substance Use: Stimulants.- Disorders Due to Substance Use: Nicotine (including tobacco and vaping).- Gambling Disorder.- Internet Gaming Disorder.- Disruptive, Impulse-Control, and Conduct Disorders: Intermittent Explosive Disorder, Kleptomania, and Pyromania.- Disruptive Impulse Control and Behavior Disorders: Oppositional Defiant Disorder and Conduct Disorder.- Somatic Symptom and Related Disorders: Factitious Disorders.- Neurocognitive Disorders.- Personality Disorders.- Paraphilic Disorders.- Relational Problems.- Culture and Psychopathology.- Systems of Care.- Prevention in Psychiatry.- Mental Health Care Models in Low-and Middle-Income Countries.- The Recovery Model and Other Rehabilitative Approaches.- Psychosocial Interventions to Support Community Living: Rehabilitation, Recovery, and Rights.- Early Intervention Across Mental Health Services.- Addressing the Social Determinants of Mental Health to Achieve Equitable Clinical Care, Research, Education, and Public Policy.- Supportive Psychotherapy.- Individual Psychodynamic Psychotherapy.- Brief Psychotherapies.- Cognitive and Behavioral Therapies.- Dialectical Behavioral Therapy.- Mindfulness-Based Cognitive Therapy.- Interpersonal Psychotherapy.- Motivational Interviewing.- Hypnosis.- Group Psychotherapy.- Family and Couple Therapy.- Mindfulness-Based Interventions for Psychiatry.- Combined Psychotherapy and Somatic Treatments.- General Principles of Pharmacologic Therapy.- Neuroscience-Based Nomenclature (NbN): New Pharmacological Driven Classification of Psychotropics.- Pharmacogenomics and Precision Psychiatry.- Cultural and Ethnic Perspectives in Psychopharmacology.- Adherence to Medication in Psychiatric Disorders.- Medications for Depression: Monoamine Enhancers and Esketamine (Antidepressants).- Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics).- Medications for Bipolar Disorder.- Medications for Anxiety Disorders.- Pharmacologic Treatment of Insomnia.- Therapeutic Use of Dopamine Enhancers (Stimulants).- Cognitive Enhancers and Treatments for Alzheimer’s Disease.- Pharmacological Treatment of Substance Use Disorders.- Medical Use of Cannabinoids and Psychedelic Compounds.- Treatments for Medication-Induced Movement Disorders.- Pharmacologic Management of Reproductive Psychopathology.- Somatic Treatments and Neuromodulation in Psychiatry.- Integrative and Complementary Medicine in Psychiatry.- Placebo and Nocebo Effects: Biological and Cultural Aspects.- Integrated and CollaborativeModels of Care.- Pediatric Consultation and Liaison Psychiatry.- Psychiatric Conditions During Peripartum and Perimenopause.- Consultation-Liaison Psychiatry and Psychological Factors Affecting Other Medical Conditions.- Collaborative Care and Geriatric Psychiatry.- Determination of Decisional Capacity.- Palliative Care and Pain Management.- Death and Bereavement.- LGBTQ Individuals.- Forensic Psychiatry.- Psychiatry in Prisons and Corrections.- Intimate Partner and Sexual Violence.- Managing Psychological Consequences in Disaster Populations.- Migration Mental Health: Immigrants, Refugees, and Displaced Persons.- Victims of Torture.- Managing Workplace Mental Health: Multiple Approaches at Patient, Provider, and Systems Levels.- Modern Psychiatric Emergency Care.- Assessment and Management of Suicidal Risk.- Assessment and Management of Violent Behavior.- Assessment and Management of Agitation.- Restraint and Seclusion.- Telepsychiatry.- Integrated Digital Platforms for Clinical Care.- Online Consumer Tools and Support.- Online Psychological Therapy.- Devices, Mobile Health and Digital Phenotyping.- Predictive Modeling, Artificial Intelligence, and Machine Learning in Psychiatric Assessment and Treatment.- Brief History of Psychiatry.- Research Methodology and Statistics.- Climate Change and Psychiatry.- Global Perspectives on Psychiatric Education.

About the Author

Allan Tasman, M.D. is Emeritus Professor and Chair of the Department of Psychiatry and Emeritus Schwab Endowed Chair in Social and Community Psychiatry at the University of Louisville. He completed residency at the University of Cincinnati and psychoanalytic training at the Western New England Institute for Psychoanalysis. He became known nationally and internationally while a faculty member at the University of Connecticut (1976–1991) for his expertise in teaching, mentorship, and educational program development. Through his subsequent national and international work, he has been involved in a broad range of educational, clinical, strategic planning, and mental health policy issues, particularly addressing disparities in health and mental health.
His commitment to serving the disadvantaged started in medical school where he founded and was CEO of the Lexington Free Clinic. While psychiatry chair in Louisville, to address health and mental health disparities in the low-income Medicaid population, he conceptualized and spearheaded implementation of Passport Health Plan in the early 1990s. This innovative non-profit managed care organization, which prioritized the quality of health outcomes and attention to health inequities, was consistently ranked nationally in the highest levels. Passport became the second largest Medicaid system in Kentucky, with a two billion dollar annual budget. He later was a 2018–2023 appointee to the National Advisory Council of the US Substance Abuse and Mental Health Services Administration (SAMHSA).

His funded research over four decades has focused on the neurophysiology of cognitive processes. His laboratory at the University of Connecticut was one of the first to describe functional neural abnormalities in offspring of alcohol addict fathers. More recent research in Louisville focused on investigation of innovative neuromodulation treatments for autism and substance abuse. He has authored or edited 38 books, over 260 peer reviewed articles, chapters, and abstracts, nearly 80 editorials in psychiatric publications, and over 400 national and international presentations. He is founding Editor in Chief of all editions of this textbook, now named Tasman’s Psychiatry, with earlier editions called “the best current textbook of psychiatry” by the New England Journal of Medicine and the “gold standard” by the American Journal of Psychiatry. He also was Editor in Chief from 2014 to 2019 of Psychiatric Times, the psychiatric publication most widely read by psychiatrists in the United States.
He was president of the American Association of Directors of Psychiatric Residency Training, the Association for Academic Psychiatry, and two terms for the American Association of Chairs of Departments of Psychiatry. As American Psychiatric Association (APA) president elect and president, he conceptualized and established the American Psychiatric Institute for Research and Education, implemented the initial planning process for DSM 5, and initiated and oversaw a complete corporate reorganization. In 1991, he founded and was Deputy Editor of the American Psychiatric Press Journal of Psychotherapy Practice and Research.
In 2005, he was elected to a 6-year term as Secretary for Education of the World Psychiatric Association, where he produced WPA global guidelines for medical student and resident psychiatric education, with special attention to programs in resource poor countries. As President of the Pacific Rim College of Psychiatrists (2006–2008), he conceptualized and established the journal Asia Pacific Psychiatry (Editor in Chief 2014–2023), which is now also the official journal of the Asian Federation of Psychiatric Associations. It is the first transnational English language psychiatric journal focused on the entire Pacific Rim region. He currently serves as Treasurer and Vice President for North America and the Caribbean of the World Federation for Mental Health, collaborating with the WHO and UN.

He has received multiple national and international awards for leadership, educational excellence, and distinguished professional service, including an APA special presidential commendation for career leadership and service. He received distinguished alumnus awards from the University of Kentucky Medical School and Franklin and Marshall College. He is a Fellow of the Royal College of Psychiatrists of the United Kingdom and a number of other organizations including Distinguished Life Fellow of the APA, and an Honorary Fellow of the World Psychiatric Association. He received the American College of Psychiatrists Distinguished Service to Psychiatry Award, their highest honor. He is the 2024 recipient of the prestigious C. Charles Burlingame Award for excellence in administration, research, and education.

Michelle B.Riba,M.D., M.S.,DFAPA, FAPM is Professor of Psychiatry, University of Michigan Medical School; Director of the PsychOncology Program at the University of Michigan Rogel Cancer Center; and Co-director of the Workplace Mental Health Program at the University of Michigan Eisenberg Family Depression Center. Dr. Riba is a board-certified consultation-liaison psychiatrist. She formerly served as Associate Chair for Education and Academic Affairs, Associate Chair for Integrated Medical and Psychiatric Services, Director of Residency Training and Director of the Consultation Liaison Fellowship in the University of Michigan Department of Psychiatry, and Associate Chair in the University of Michigan Comprehensive Depression Center. She has served as President of the American Psychiatric Association, Association for Academic Psychiatry, and American Association of Directors of Psychiatric Residency Training, as well as Secretary for Scientific Publication of the World Psychiatric Association and on the Board of the Directors of the Pacific Rim College of Psychiatrists. Dr. Riba is Chair of the National Comprehensive Cancer Network (NCCN) Distress Guidelines, as well as a member of the NCCN Fatigue Guidelines. She has served as the American Medical Association’s representative to the American College of Surgeons Commission on Cancer, the AAMC Council of Academic Societies-Leadership Development Committee, the World Federation for Mental Health Scientific Committee and Program Chair, and the Association of Women Psychiatrists Executive Council; Trustee of the American Association for Emergency Psychiatry, the Society for Clinical and Translation Science, American College of Psychiatrists PRITE Commission, and Institute of Medicine Committee on Incorporating Research into Psychiatry Residency Training.
Dr. Riba received the Nancy C.A. Roeske, MD APA Award for Excellence in Medical Student Teaching from the University of Connecticut and the University of Michigan; the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women; the APA Irma Bland Award for Excellence in Teaching Residents; the Outstanding Clinician Award from the University of Michigan; the University of Michigan Making a Difference Award; Special Recognition Award from the Academy of Psychosomatic Medicine; Inaugural member, Distinguished Life Fellows, Association for Academic Psychiatry; American College of Psychiatrists Distinguished Service Award; American Psychiatric Association Distinguished Service Award; Association of Women Psychiatrists/APA Alexandra Symonds Award; and Special Recognition Award, Indo-American Psychiatric Association for Leadership Exceptional Achievements and Dedication to Minority Psychiatrists. She is the 2024 recipient of the Academy of Consultation-Liaison Psychiatry Distinguished Service Award.
Dr. Riba is the author or editor of over 300 scientific articles, books, chapters, and scientific abstracts. She is Editor-in-Chief, Current Psychiatry Reports, Springer. Dr. Riba has served on the editorial board of Psychiatric Services and Cancer News on the Net, Current Psychiatry, Academic Psychiatry, and Hospital and Community Psychiatry, and has served on the editorial advisory board of the American Psychiatric Press, Inc. She is a reviewer for many international journals, including Psycho-Oncology, Academic Psychiatry, Psychiatric Services, Journal of Psychiatric Practice, Psychosomatic Medicine, and Breast Cancer Research and Treatment. She has co-edited fifteen editions of the American Psychiatric Press Review of Psychiatry series. She has co-edited Psychopharmacology and Psychotherapy: A Collaborative Approach, APPI, Inc.; Primary Care Psychiatry, Saunders; The Doctor-Patient Relationship in Pharmacotherapy: Improving Treatment Effectiveness, Guilford; and Psychopharmacology in Oncology and Palliative Care: A Practice Manual, Springer. Dr. Riba has edited or co-written over 40 books. She is the senior author of Competency in Combining Pharmacotherapy and Psychotherapy, APPI, Inc.; Clinical Manual of Emergency Psychiatry, APPI, Inc. (First and Second Edition); Psychiatry and Heart Disease, John Wiley and Sons, Inc.; Physician Mental Health and Well-Being, Springer; Workplace Mental Health, Springer; and College Psychiatry, Springer. She has served on the international advisory board of the journal Academic Psychiatry and was Deputy Editor of Psychiatric Times.
Dr. Riba has a wonderful family—married to Arthur L. Riba, M.D. for over 52 years. They have two daughters, Alissa B. Roger, J.D., and Erica B. Riba, MSW, son-in-law, James M. Roger, DDS, and the most marvelous grandchildren, Oscar Thomas, and Jean Badian Roger. Michelle loves to play tennis, kayak, and piano; and be with family, friends, and colleagues. Dr. Riba is indebted to her patients and their families for the honor and privilege to serve as their physician.

Renato D. Alarcón, MD, MPH is Distinguished Emeritus Professor in the Department of Psychiatry and Psychology at Mayo Clinic School of Medicine, Rochester, Minnesota. He is also Emeritus Professor and Honorio Delgado Chair at the Universidad Peruana Cayetano Heredia (UPCH) in Lima, Perú, where he obtained his MD degree in 1965. He completed his Psychiatric Residency and Fellowships in Psychosomatic Medicine and Clinical Psychopharmacology at Johns Hopkins Hospital and earned his MPH degree at the Hopkins School of Public Health (1967–1972). Between 1972 and 1980, he organized and conducted the first academically based psychiatric Residency program in Peru at the UPCH and was Associate Dean and Director of Academic Programs before returning to the U.S. He occupied leadership positions in the Departments of Psychiatry at the University of Alabama in Birmingham (1980–1992) and Emory University School of Medicine in Atlanta, GA (1992–2002), before joining Mayo Clinic where he was Chief of the Adult Psychiatry Division and the Mood Disorders Program (2002–2015).
He was Secretary General of the World Association of Cultural Psychiatry (WACP) between 2015 and 2018 and has also served in numerous Committees of the American Psychiatric Association, including the DSM Steering Committee and its Personality Disorders Work Group and Equity and Inclusion Subcommittee.
Author or co-author of over 270 articles and author/editor of 26 books and 130 book chapters, Dr. Alarcón is Senior Editor of the most widely read psychiatric textbook in Latin America (four editions) and board member of several publications in the continent. He has received, among other distinctions, the APA Simon Bolivar and George Tarjan Awards, and the WACP Weng Shing Tseng and Jean Garrabé Awards. He has received honorary membership of several international academic institutions in the U.S., Europe, and Latin America. His academic and clinical interests include personality and mood disorders, PTSD, psychiatric diagnosis, global mental health, and cultural psychiatry.

César A. Alfonso, M.D. is Clinical Professor of Psychiatry at Columbia University, Adjunct Professor at the University of Indonesia, and Visiting Professor at Prince of Songkla University in Thailand, and at the National University of Malaysia. He serves as Editor of Psychodynamic Psychiatry (2020–present). Born in Cuba, he spent formative years in Spain and Puerto Rico before pursuing undergraduate studies at Yale University, and graduate and postgraduate studies in medicine, psychiatry, psychosomatic medicine, and psychoanalysis at New York Medical College. During the first half of his career, he was Director of the Division of Consultation-Liaison Psychiatry at Metropolitan Hospital-New York Medical College, with a focus on HIV Psychiatry and Psycho-oncology. He also chaired the hospital’s Ethics Committee. Dr. Alfonso served as President of the American Academy of Psychodynamic Psychiatry and Psychoanalysis in 2010–2012 and remains Chair of the Psychoanalytic Education Committee. He served as Chair of the Psychotherapy Section of the World Psychiatric Association in 2017–2023 and is the current President of the World Federation for Psychotherapy (2023–2026). His recent work includes biopsychosocial aspects of suicide, the care of visually impaired persons, bidirectionality and comorbidity, psychotherapy as a biological treatment, psychoanalysis and creativity, cultural anthropology and psychotherapy, and the design and implementation of psychotherapy training programs worldwide. He is a Distinguished Fellow of the American Psychiatric Association and is a Fellow of the New York Academy of Medicine, the Academy of Consultation-Liaison Psychiatry, and the American Academy of Psychodynamic Psychiatry and Psychoanalysis. He served as a Teichner Scholar with Visiting Professorships at Northwell Staten Island and the University of Iowa. He has over 100 publications, including books: Advances in Psychodynamic Psychiatry (Guilford Press, 2018), Suicide by Self-Immolation: Biopsychosocial and Transcultural Aspects (Springer Nature, 2021), and the 5th Edition of Tasman’s Psychiatry (Springer Nature, 2024). He is Editor of the 3rd Edition of Cohen’s Comprehensive Textbook of AIDS Psychiatry (Springer Nature, est. 2027). For the past 15 years, he has been the Chief Psychiatrist at the Lighthouse Guild Behavioral Health Clinic, a mental health clinic dedicated to the care of persons with vision loss or who are blind.

Shigenobu Kanba, M.D., Ph.D. Current appointments are Professor Emeritus, Kyushu University, Japan; Japan Depression Center, President; Iida Hospital (Nagano), Advisor; and Fukuoka Institute of behavioral Medicine, all since 2019.
Education and Employment
Keio University School of Medicine, Tokyo: 1980
Keio University Hospital, Intern: 1980–1981
Mayo Clinic, Research Fellow (Pharmacology): 1982–1983
Mayo Clinic, Resident (Psychiatry) and Assistant professor (Psychiatry): 1984–1987
Keio University School of Medicine, Assistant and Assistant Professor (Psychiatry): 1987–1996
Yamanashi University School of Medicine, Professor (Psychiatry): 1996–2003
Kyushu University Graduate School of Medicine, Professor and Chairman (Psychiatry): 2003–2019
Research and Editorial Activity
Research areas have focused on mood disorders, psychoneuroimmunology, and psychopharmacology. He has published more than 400 scientific papers (h-index ¼ 68) and 14 book chapters in English (as of January 2024). He is emeritus editor-in-chief of Psychiatry and Clinical Neurosciences, editor of Current Opinion of Psychiatry, International Journal of Bipolar Disorders, Irish Journal of Psychological Medicine, Asia-Pacific Psychiatry, Pharmacopsychiatry, Neurology, Psychiatry and Brain Research, Asian Journal of Psychiatry, and Indian Journal of Psychiatry.
Organization Leadership
He served as President, Japanese Society of Psychiatry and Neurology; Executive Secretary, Japanese Association of Medical Sciences and Japanese Medical Science Federation; Vice President, International Society of Bipolar Disorders; President, Asian Federation of Psychiatric Societies; and Associate Secretary-Treasurer, World Federation of Societies of Biological Psychiatry,
WFSBP.
Government Leadership
Currently, he is program supervisor and program officer of the Japan Agency for Medical Research and Development and an advisory member of the Japan Science and Technology Agency. He serves the Tokyo Metropolitan Institute of Medical Science as a director and serves/served on the Science Council of Japan, Strategy Committee of Health and Medicine of Japanese Cabinet Office, Social Security Committee of Japanese Ministry of Health, Labor and Welfare, Drug and Food Administration, and the Brain Science Committee of the Japanese Ministry of Education, Culture, Sports, Science and Technology. He was an advisory member of Japan Society for the Promotion of Science.
Awards and Honors
American Psychiatric Association, Pennwalt Award, 1985
Mayo Clinic, Balfour Award, 1987
Mayo Clinic, Rome, H. Award, 1987
CINP, Rafaelsen Award, 1988
Kyushu University Research Award, 2012–2016
Minister of Health, Labor and Welfare Commendation, 2020
Honorary Member of the World Psychiatric Association

Dusica Lecic-Tosevski, MD, PhD is a full member of the Serbian Academy of Sciences and Arts, psychiatrist, psychotherapist and professor of psychiatry. She was the director of the Institute of Mental Health, the university psychiatric hospital, from 2004 to 2019, and was internationally awarded as the best leader. She has been the founder and head of the WHO Collaborating Centre for Mental Healthcare Force Development and the WHO national counterpart for mental health. Chairing the National Committee for Mental Health, she has made a significant contribution to the reform of mental health care in the country and has been an editor of the National Strategy for Mental Health Care. In the past, she was a coordinator of several programs for mental health care of refugees and torture victims. Prof. Lecic-Tosevski has been actively involved in WPA, as past zonal representative for Central Europe, past chair of the Section on Preventive Psychiatry, and co-chair of the Committee for Scientific Publications, and is a member of the board of the Section Psychoanalysis and Psychiatry, as well as of other sections. 
She is APA distinguished fellow, International Associate of the Royal College of Psychiatry, EPA Fellow, WPA honorary member, president of the Psychiatric Association of Eastern Europe and the Balkans, of the Serbian Association of Social Psychiatry, and past president of the Serbian Psychiatric Association (now its honorary president). She has been a member of the WHO Working Group on ICD-11 Classification of Personality Disorders.
Prof. Dusica Lecic-Tosevski has been a coordinator and investigator of many international, multicentric, and national research projects. She authored numerous scientific articles and chapters in international handbooks and books; is editor of two international books, the national textbook of psychiatry, three books at the Academy of Sciences and Arts, as well as guidelines for evidence based treatment of depression and schizophrenia and many practical manuals. She is a member of editorial boards and reviewer of numerous international journals and has given invited talks at many international congresses and universities, some of which she has organized. She has translated seven professional and six literature works. 
Professor Lecic-Tosevski’s professional interests are personality disorders, affective disorders, traumatic stress, and comorbidity of mental and somatic disorders. She has devoted her professional life to the noble discipline of psychiatry, improvement of person-centered treatment of mental disorders, as well as their prevention and mental health promotion.

David M. Ndetei is a Professor of Psychiatry University of Nairobi, Kenya, the Founding Director of Africa Mental Health Research and Training Foundation (AMHRTF) now rebranded as “Africa Institute of Mental and Brain Health” and the Director of World Psychiatric Association Collaborating Centre for Research and Training, Kenya. Over the last 20 years, AMHRTF has become a leading center in the region in mental health and brain health research. It has partnerships and collaborators across Africa and many countries, both low and middle-income countries and high-income countries. Our emphasis is on the community approach for innovative interventions that are social-culturally context appropriate, affordable, available, accessible, and evidencebased with potential for critical reach. AMHRTF takes a family oriented, multi-disciplinary, multistakeholder, and policymaker approach to research from design, implementation, and validation of results for shared ownership and therefore seamless transition from research/programs to policy and practice uptake. He has trained nearly all senior psychiatrists in Kenya and some from the region. Recently, he was ranked as one of the two top scientific researchers in Kenya. He has 417 scholarly publications including authoring 6 books and 21 monographs. He is also editing a book titled “Global Mental Health in Africa: Towards Inclusivity, Innovations and Opportunities.” It is to be published in the United Kingdom (UK). It has 150 contributors drawn globally but mainly from Africa.
He has pioneered local training for psychiatrists in Kenya; training of clinical psychologists at the University of Nairobi, postgraduate diplomas in psychiatric social work, psychotrauma, substance use and abuse, and clinical psychiatry (just below the level of a psychiatrist) at the University of Nairobi. In his academic career, he has put emphasis on mentoring students for their Masters, Ph.D., and Doctor of Science (D.Sc.), which is a higher doctorate, as well as postdoc fellowships from across the globe. He is a member of various professional bodies and honorary official of various academic institutions and associations across the globe.

Prof. Chee Ng, MBBS (Melb), MMed (Psych), FRANZCP, MD currently holds the position of Healthscope Chair of Psychiatry at the Melbourne Clinic and Professor of Psychiatry in the Department of Psychiatry, the University of Melbourne. The Melbourne Clinic is Australia’s largest private psychiatric hospital, which provides a comprehensive inpatient program, day program center, and an outreach service. The Professorial Unit of the Melbourne Clinic delivers specialized treatment for mood and anxiety disorders with complex problems through a multidisciplinary team, which include biological, psychosocial, and cognitive approaches. It conducts academic teaching for university MD students and psychiatric trainees, as well as psychiatric research innovations providing synergy between clinical practice and research for best evidence treatments. 
He has considerable research experience in psychopharmacology, pharmacogenetics, mood and anxiety disorders, schizophrenia, old age, and cross-cultural psychiatry. He has published over 400 original articles in peer-reviewed journals and more than 25 book chapters and is the Editor-in-Chief of the Asia-Pacific Psychiatry Journal. He is currently an Executive Committee Member of the APEC Mental Health Digital Hub and Past President of the Pacific Rim College of Psychiatrists, and Fellow of the Royal Australian and New Zealand College of Psychiatrists.
He is also appointed as Director of World Health Organisation Collaborating Center in Mental Health Research and Training at St. Vincent’s Hospital Melbourne, where he is also senior Consultant Psychiatrist and Director of the International Psychiatry Unit which was awarded the St. Vincent’s Australia National Award 2010 for Community Service. He had led the Postgraduate Overseas Specialists Training (POST) Program which has trained over 500 international psychiatrists, nurses, and mental health professionals. In this capacity, he co-founded Asia-Australia Mental Health which supported mental health development in the Asia-Pacific region. He was an Advisory Committee member of the China-Australia Community Mental Health Program for China’s national community mental health program and a consultant of Community Mental Health at Shenzhen Mental Health Center. He previously led the Asia-Pacific Community Mental Health Development Project, involving 18 Asia-Pacific countries. He also served as an international mental health consultant for WHO, the Commonwealth of Nations, and Asia-Pacific Economic Cooperation. He has collaborated in major national projects in numerous countries, including China, India, Japan, Vietnam, Laos, Cambodia, Malaysia, Myanmar, Qatar, and Solomon Islands.

Prof. Thomas G. Schulze born in 1969, studied medicine in Erlangen (Bavaria), Manama (Bahrain), Barcelona (Catalonia), and Chapel Hill and Winston-Salem (both North Carolina). He trained as a psychiatrist and held various positions in Germany (Bonn, Mannheim, Göttingen, Munich) and the USA (Chicago, IL; Bethesda, MD; Baltimore, MD; Syracuse, NY). 
Since 2014, he has held the position of Chair and Director of the Institute of Psychiatric Phenomics and Genomics (www.ippg.eu) at the Ludwig-Maximilians-University of Munich (IPPG). He is a research affiliate with the National Institute of Mental Health (NIMH) in Bethesda, MD, and on Faculty with the Department of Psychiatry and Behavioral Sciences of Johns Hopkins University, Baltimore, MD. In 2019, he also joined the Faculty of the Department of Psychiatry and Behavioral Sciences of SUNY Upstate Medical University, Syracuse, NY, USA, where he holds an appointment as clinical professor. He is licensed to practice medicine in the European Union and the State of New York. 
Dr. Schulze’s research focuses on genotypephenotype relationships and personalized medicine approaches in psychiatric disorders. He coordinates a German-wide center grant on longitudinal psychosis research (www.PsyCourse.de) and spearheads an international study on the genetic basis of response to lithium treatment in bipolar disorder (www.ConLiGen.org), comprising several research groups from Europe, the Americas, Asia, and Australia. He has authored over 300 papers, and his h-index being 70 (Web of Science) and 95 (Google Scholar), respectively. In addition to national German awards, he is the 2006 recipient of the Robins-Guze Award of the American Psychopathological Association (APPA), the 2006 recipient of the Theodore-Reich-Award of the International Society of Psychiatric Genetics (ISPG), and the winner of the Colvin Prize 2016 of the Brain and Behavioral Research Foundation (BBRF). He is a Fellow of the American College of Neuropsychopharmacology (ACNP) and the APPA and served as President of the APPA from 2015 through 2016. Between 2016 and 2020, he also held the office of President of the ISPG. From 2011 through 2017, he served as the Chair of the Section on Psychiatric Genetic of the World Psychiatric Association (WPA), in which he is an honorary member. In 2017, he was elected to the Executive Committee of the WPA, starting a 6-year term as Secretary of Scientific Sections. In 2021, he was elected to the German Academy of Sciences (Leopoldina.org). In 2023, he was elected President-Elect of the WPA, with the 3-year term as President commencing in 2026. Thomas G. Schulze speaks German, English, French, Catalan, Spanish, and Latin and has a basic knowledge of Arabic.